Congress Asset Management Co. raised its stake in The Procter & Gamble Company (NYSE:PG - Free Report) by 6.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 43,601 shares of the company's stock after purchasing an additional 2,737 shares during the quarter. Congress Asset Management Co.'s holdings in Procter & Gamble were worth $7,310,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of PG. Patrick M Sweeney & Associates Inc. increased its stake in shares of Procter & Gamble by 1.1% in the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company's stock valued at $963,000 after acquiring an additional 59 shares during the last quarter. Valued Wealth Advisors LLC increased its stake in Procter & Gamble by 11.2% in the third quarter. Valued Wealth Advisors LLC now owns 605 shares of the company's stock valued at $105,000 after purchasing an additional 61 shares in the last quarter. Colton Groome Financial Advisors LLC raised its holdings in Procter & Gamble by 3.2% in the fourth quarter. Colton Groome Financial Advisors LLC now owns 1,995 shares of the company's stock worth $334,000 after purchasing an additional 62 shares during the period. Tevis Investment Management boosted its position in shares of Procter & Gamble by 0.6% during the fourth quarter. Tevis Investment Management now owns 11,633 shares of the company's stock worth $1,950,000 after purchasing an additional 65 shares in the last quarter. Finally, Dakota Community Bank & Trust NA grew its holdings in shares of Procter & Gamble by 3.3% in the 4th quarter. Dakota Community Bank & Trust NA now owns 2,078 shares of the company's stock valued at $348,000 after buying an additional 66 shares during the period. Institutional investors and hedge funds own 65.77% of the company's stock.
NYSE PG opened at $162.84 on Monday. The company has a market cap of $381.84 billion, a PE ratio of 25.93, a PEG ratio of 3.79 and a beta of 0.45. The Procter & Gamble Company has a 12 month low of $153.52 and a 12 month high of $180.43. The stock has a 50 day moving average of $166.51 and a 200-day moving average of $169.46. The company has a current ratio of 0.76, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Wednesday, January 22nd. The company reported $1.88 EPS for the quarter, beating analysts' consensus estimates of $1.86 by $0.02. The company had revenue of $21.88 billion during the quarter, compared to the consensus estimate of $21.66 billion. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The company's quarterly revenue was up 2.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.84 EPS. On average, equities research analysts anticipate that The Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th will be given a $1.0065 dividend. The ex-dividend date is Friday, January 24th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.47%. Procter & Gamble's payout ratio is 64.17%.
Several research analysts have weighed in on PG shares. Royal Bank of Canada reiterated a "sector perform" rating and set a $164.00 target price on shares of Procter & Gamble in a report on Thursday, January 23rd. Barclays boosted their price objective on Procter & Gamble from $155.00 to $159.00 and gave the company an "equal weight" rating in a research report on Thursday, January 23rd. Evercore ISI increased their target price on Procter & Gamble from $180.00 to $183.00 and gave the stock an "outperform" rating in a research note on Monday, October 21st. Wells Fargo & Company lifted their price target on shares of Procter & Gamble from $176.00 to $180.00 and gave the company an "overweight" rating in a research note on Thursday, January 23rd. Finally, Morgan Stanley increased their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an "overweight" rating in a research report on Monday, October 21st. Eight investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $180.53.
View Our Latest Analysis on PG
In other news, insider Balaji Purushothaman sold 12,800 shares of the business's stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the completion of the sale, the insider now owns 11,595 shares in the company, valued at $2,002,804.35. The trade was a 52.47 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Marc S. Pritchard sold 90,450 shares of the stock in a transaction that occurred on Thursday, January 23rd. The stock was sold at an average price of $163.84, for a total value of $14,819,328.00. Following the transaction, the insider now owns 172,814 shares in the company, valued at approximately $28,313,845.76. This trade represents a 34.36 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 151,097 shares of company stock worth $25,635,076. 0.18% of the stock is owned by company insiders.
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.